41. Giant cell arteritis Clinical trials / Disease details

Clinical trials : 131 / Drugs : 139 - (DrugBank : 36) / Drug target genes : 33 - Drug target pathways : 125

4 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05623592 (ClinicalTrials.gov)	November 23, 2022	8/11/2022	Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis	A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of Methotrexate as Remission Maintenance Therapy After Remission-Induction Therapy With Tocilizumab and Glucocorticoids in Subjects With Giant Cell Arteritis	Giant Cell Arteritis	Drug: Methotrexate;Drug: Sodium chloride	University of Bonn	NULL	Recruiting	18 Years	N/A	All	40	Phase 2	Germany
2	NCT03745586 (ClinicalTrials.gov)	December 1, 2018	6/11/2018	Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab	Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab	Giant Cell Arteritis	Drug: Tocilizumab;Drug: Glucocorticoids	University Hospital Inselspital, Berne	NULL	Completed	50 Years	N/A	All	18	Phase 1/Phase 2	Switzerland;Italy
3	NCT01450137 (ClinicalTrials.gov)	September 2011	3/10/2011	Tocilizumab for Patients With Giant Cell Arteritis	A Phase II, Randomized, Double-blind, Placebo Controlled Study of Tocilizumab in Patients With Giant Cell Arteritis	Giant Cell Arteritis	Drug: Tocilizumab + Glucocorticoids (GCs);Drug: Placebo + Glucocorticoids (GCs)	University Hospital Inselspital, Berne	University of Bern;Roche Pharma AG	Completed	50 Years	N/A	All	30	Phase 2	Switzerland
4	NCT00004686 (ClinicalTrials.gov)	February 1994	24/2/2000	Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis		Giant Cell Arteritis	Drug: methotrexate;Drug: prednisone	The Cleveland Clinic	NULL	Completed	50 Years	N/A	Both	300	Phase 2	NULL